Neuroendocrine tumour – Life with Disease

Go back

Neuroendocrine tumours are a group of uncommon cancers that develop in cells combining characteristics of nerve and hormone-producing cells throughout the body, with outcomes and treatment approaches varying widely based on the tumour’s location, growth rate, and individual characteristics.

Understanding Your Prognosis

When you receive a diagnosis of neuroendocrine tumour, it’s natural to wonder about what lies ahead. The outlook for people with this condition varies considerably depending on several important factors. Each person’s journey is unique, and understanding your specific situation requires careful consideration of where the tumour is located, how quickly it grows, and whether it has spread to other parts of your body[1].

Many neuroendocrine tumours, often called NETs, grow slowly over time. This characteristic means that even when they are discovered at advanced stages, people can often live for many years with the disease. Some NETs are caught early enough that surgery can remove them completely, offering the possibility of cure. When surgical removal is possible, especially at early stages, patients should be monitored for at least ten years to ensure the cancer doesn’t return[8].

The prognosis depends heavily on the tumour’s grade, which tells doctors how abnormal the cells look under a microscope and how quickly they’re dividing. Well-differentiated tumours that grow slowly generally have a better outlook than poorly differentiated ones that multiply rapidly[6]. Your doctors will also consider whether your tumour produces excess hormones, which can affect both symptoms and treatment options.

For many patients diagnosed with neuroendocrine tumours, the disease can be controlled for extended periods, even when it has spread to other organs. Advances in treatment options mean that more people are living longer with this condition than ever before. Early diagnosis and treatment continue to increase the number of people living for years with NET[2].

⚠️ Important
Not everyone wants to know detailed information about their outlook, and that’s perfectly acceptable. Survival statistics can be useful but cannot predict exactly what will happen to you as an individual. The best person to discuss your specific prognosis is your doctor, who knows your complete medical picture. You can choose to read information when you feel ready, or not at all.

How the Disease Progresses Naturally

Without treatment, neuroendocrine tumours follow different paths depending on their type and location. The defining characteristic of most NETs is their tendency to grow slowly, which distinguishes them from many other cancers. This slow growth pattern means that in some cases, these tumours may have been developing in your body for years before causing any noticeable symptoms[23].

As the tumour grows over time, it can begin to affect the organ where it originated. For example, a neuroendocrine tumour in the digestive system might eventually cause blockages or interfere with normal digestion. Tumours in the lungs might lead to breathing difficulties. The timeline for these changes varies greatly from person to person, and some tumours remain small and stable for long periods without causing problems.

One significant concern with untreated neuroendocrine tumours is their potential to spread beyond their original location. The liver is a common site where these tumours spread, particularly when they start in the digestive system. When NETs reach the liver, they can multiply and create multiple tumours throughout this vital organ[23]. This spreading process, called metastasis, happens when cancer cells break away from the original tumour and travel through the bloodstream or lymphatic system to establish new tumours elsewhere.

Some neuroendocrine tumours are classified as functional tumours, meaning they produce excessive amounts of hormones. Without treatment, these hormone levels can continue to rise, leading to increasingly severe symptoms. The specific hormones involved depend on the tumour’s location and type. Over time, these hormonal imbalances can significantly affect your body’s normal functioning and quality of life.

It’s important to understand that not all neuroendocrine tumours behave the same way. Some remain small and grow so slowly that they may not require immediate treatment, while others are more aggressive and need prompt intervention. Your medical team can help you understand how your specific tumour is likely to behave based on its characteristics.

Possible Complications

Neuroendocrine tumours can lead to various complications that affect different parts of your body. Understanding these potential problems helps you and your medical team watch for warning signs and address issues promptly.

One of the most distinctive complications is carcinoid syndrome, which occurs in some people whose tumours produce large amounts of hormones, particularly a substance called serotonin. This syndrome causes a characteristic set of symptoms including sudden flushing of the skin, particularly on the face and neck, severe diarrhoea that can occur multiple times daily, painful gas and bloating, and sometimes wheezing or difficulty breathing[5]. These symptoms can be triggered by certain foods, alcohol, or stress, making daily life unpredictable and challenging.

When carcinoid syndrome persists over time, it can lead to a serious heart complication where the valves on the right side of the heart become damaged and scarred. This happens because the excess hormones produced by the tumour pass through the heart before being broken down by the liver. The damaged valves may not work properly, potentially leading to heart failure if not monitored and managed appropriately.

Another urgent complication is carcinoid crisis, a life-threatening situation where hormone levels suddenly spike to dangerous levels. This can cause a severe drop in blood pressure, extreme flushing, rapid heartbeat, confusion, and difficulty breathing. Carcinoid crisis can be triggered by surgery, anaesthesia, stress, or certain medications. Medical teams must be aware of your NET diagnosis before any surgical procedure to prevent this complication.

When neuroendocrine tumours spread to the liver, they can significantly impair this organ’s ability to perform its vital functions. The liver processes nutrients, produces proteins needed for blood clotting, and removes toxins from your body. As tumours grow in the liver, you might experience abdominal pain and swelling, yellowing of the skin and eyes (jaundice), and general weakness. Extensive liver involvement can also make it harder for your body to process the excess hormones produced by functional tumours.

Tumours located in the digestive system can cause blockages that prevent food from moving normally through your intestines. This obstruction can lead to severe pain, nausea and vomiting, inability to pass gas or have bowel movements, and dangerous swelling of the abdomen. These blockages may require emergency intervention.

Some people develop nutritional deficiencies because their tumours or previous surgeries affect how the body absorbs vitamins and minerals from food. For instance, tumours or surgical removal of parts of the small intestine can interfere with the absorption of vitamin B12, iron, and fat-soluble vitamins. This can lead to anaemia, fatigue, and other health problems that need specific nutritional support[20].

Impact on Daily Life

Living with neuroendocrine tumours affects many aspects of everyday life, from physical abilities to emotional well-being, relationships, and work. Understanding these impacts can help you prepare and find ways to maintain your quality of life.

Physically, the symptoms of NETs can be unpredictable and disruptive. If you experience carcinoid syndrome, sudden flushing episodes can occur at inconvenient times, causing embarrassment in social or professional situations. Severe diarrhoea may make you reluctant to leave home or require you to always know where bathrooms are located. Fatigue is common, affecting your ability to complete daily tasks, maintain your usual activity level, or fulfil work responsibilities[2].

The chronic nature of neuroendocrine tumours creates unique emotional challenges. Unlike some cancers that follow a clear treatment path with a defined endpoint, many people with NETs face ongoing uncertainty. You might feel reasonably well for extended periods, making it easy to temporarily forget about the cancer, but regular scans and appointments bring the reality back into focus. This creates an emotional rollercoaster that many patients describe as exhausting[17].

Many people experience a complex mix of emotions including fear about the future, frustration with unpredictable symptoms, and anxiety before medical appointments or scans. Some feel isolated because friends and family don’t fully understand this uncommon type of cancer. Others struggle with the challenge of explaining to people that they have cancer but might not look sick or receive the intensive treatments that people associate with cancer care.

Social relationships can be affected in various ways. You might need to decline invitations or leave events early because of symptoms. Dietary restrictions necessary to manage carcinoid syndrome mean you may not be able to enjoy meals the way you once did, particularly at restaurants or social gatherings where you have less control over food preparation[20]. Some people find that friends gradually stop inviting them to activities, either because of past cancellations or because they don’t know how to interact with someone who has cancer.

Work life often requires adjustments. Frequent medical appointments for treatments, scans, and consultations with various specialists can accumulate, requiring time away from work. Some treatments cause fatigue or other side effects that make it difficult to maintain your previous work schedule. You may need to have conversations with employers about flexible working arrangements or reduced hours. For some people, the disease eventually makes it impossible to continue working, creating financial stress on top of medical concerns.

Hobbies and activities you previously enjoyed might need modification. Physical activities may become more challenging due to fatigue or surgical recovery. Travel requires extra planning to ensure access to medical care and management of symptoms. However, many people find ways to continue activities that bring them joy by making adaptations and setting realistic expectations[17].

⚠️ Important
Taking care of your emotional health is just as important as treating the physical disease. Many people benefit from counselling, joining support groups where they can connect with others who understand their experience, or learning stress-management techniques like meditation. Don’t hesitate to ask your medical team about mental health support services.

Despite these challenges, many people with neuroendocrine tumours maintain good quality of life, especially when symptoms are well-controlled. Staying informed about your condition, working closely with your medical team, and finding a support network that works for you can help you navigate the practical and emotional aspects of living with NETs. Many patients report that they learn to adapt to a “new normal” where they can still enjoy meaningful activities and relationships while managing their health condition.

Support for Family and Loved Ones

If someone you care about has been diagnosed with neuroendocrine tumours, you play a vital role in their journey. Understanding what they’re facing and how you can help makes a significant difference to their well-being and treatment experience.

One of the most valuable things you can do is learn about neuroendocrine tumours yourself. Because NETs are uncommon, many people have never heard of them, which can make patients feel isolated. Taking time to understand the basics of the disease, how it differs from other cancers, and what treatment options exist shows your loved one that you’re committed to supporting them. You don’t need to become an expert, but having foundational knowledge helps you understand what they’re experiencing.

Clinical trials represent an important treatment option for many people with neuroendocrine tumours. These research studies test new treatments or new combinations of existing treatments to find better ways to manage the disease. Your loved one’s doctors may suggest considering a clinical trial at some point in their care. As a family member or friend, you can help by discussing this option with them, accompanying them to appointments where trials are explained, and helping them weigh the potential benefits and risks.

Finding suitable clinical trials can feel overwhelming when dealing with a cancer diagnosis. You can assist by helping search for trials that match your loved one’s specific type of NET, using online databases provided by cancer organisations, and keeping organised records of trials that might be suitable. Many specialised NET centres have coordinators who can help identify appropriate studies, but having an extra pair of eyes and hands to gather information can be tremendously helpful.

Preparing for clinical trial participation involves practical steps where family support proves invaluable. Trials often require additional appointments, travel to specialised centres, and careful tracking of symptoms and side effects. You might help by arranging transportation to appointments, taking notes during meetings with research coordinators, asking questions that your loved one might not think of, or helping maintain records of treatments and symptoms. Your organisational support can reduce the burden on the patient and ensure they can focus on their health.

Beyond clinical trials, there are many ways to provide day-to-day support. Accompanying your loved one to medical appointments means they have someone to help remember what doctors said, ask questions they might forget, and provide emotional support during difficult conversations. Keeping a calendar of appointments and treatments prevents scheduling conflicts and ensures nothing is missed. Helping with practical tasks like meal preparation, household chores, or childcare during treatment days reduces stress and allows the patient to rest when needed.

Emotional support is equally important as practical help. Living with neuroendocrine tumours can be lonely and frightening. Simply being present, listening without trying to fix everything, and acknowledging that this is difficult can provide enormous comfort. Avoid minimising their experience with phrases like “at least it’s not worse” or “you don’t look sick.” Instead, let them know you’re there for them regardless of how they’re feeling.

Some families find it helpful to designate one person to coordinate communication with extended family and friends, sparing the patient from repeatedly explaining their situation. This coordinator can share updates, organise help when needed, and protect the patient’s privacy and energy.

Remember that supporting someone through cancer treatment is demanding, and you need to take care of yourself too. Seeking support from friends, joining caregiver support groups, or speaking with a counsellor helps you maintain your own well-being so you can continue being there for your loved one over the long term. Taking breaks, maintaining your own activities and relationships, and acknowledging your own feelings about the situation aren’t selfish—they’re necessary for sustainable support.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Lanreotide – A somatostatin analogue given as monthly injections that blocks growth hormones feeding slow-developing tumours and helps control hormone levels in functional NETs
  • Somatostatin analogues – Medicines that reduce and control high hormone levels produced by some NETs, often used as first-line therapy for low or intermediate grade tumours and well-tolerated for many years
  • Telotristat – An emerging agent used for controlling carcinoid syndrome and related complications

Ongoing Clinical Trials on Neuroendocrine tumour

  • Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

    Recruiting

    1 1
    France Italy Spain
  • Study on the Effect of Octreotide and Lanreotide in Peptide Receptor Radionuclide Therapy for Adults with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Belgium The Netherlands
  • Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Sweden
  • Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany
  • Study on Long-term Safety of Satoreotide Tetraxetan Lutetium-177 for Patients with Somatostatin Receptor Positive Neuroendocrine Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy The Netherlands Spain
  • Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

    Not recruiting

    1 1 1
    Investigated diseases:
    France Poland Spain

References

https://www.mayoclinic.org/diseases-conditions/neuroendocrine-tumors/symptoms-causes/syc-20354132

https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net

https://www.mdanderson.org/cancerwise/neuroendocrine-tumors–9-things-to-know.h00-159379578.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10420169/

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets

https://en.wikipedia.org/wiki/Neuroendocrine_tumor

https://www.neuroendocrinecancer.org.uk/neuroendocrine-cancer/understanding-neuroendocrine-cancer/

https://neuroendocrine.org.au/what-are-nets/

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroendocrine-tumor

https://www.mayoclinic.org/diseases-conditions/neuroendocrine-tumors/diagnosis-treatment/drc-20465865

https://www.mdanderson.org/cancer-types/neuroendocrine-tumors/neuroendocrine-tumor-treatment.html

https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/treatment

https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/treatment.php

https://neuroendocrine.org.au/treatments/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6378464/

https://www.neuroendocrinecancer.org.uk/neuroendocrine-cancer/living-with-neuroendocrine-cancer/

https://netrf.org/old-for-patients/living-with-nets/symptom-management/

https://www.cancerresearchuk.org/about-cancer/neuroendocrine-tumours-nets/living-with/coping

https://www.livingwithnets.com/living-with-neuroendocrine-tumours-nets/diet-and-nutrition/

https://www.webmd.com/cancer/neuroendocrine-tumors-feel-better

https://www.mdanderson.org/cancerwise/neuroendocrine-tumors–9-things-to-know.h00-159379578.html

https://www.uchicagomedicine.org/forefront/cancer-articles/2023/september/pancreatic-nets-patient-chris-meyer

FAQ

Are neuroendocrine tumours always cancerous?

Most neuroendocrine tumours are malignant, meaning they are cancerous. However, they vary greatly in how aggressively they behave. Some grow so slowly that they may not require immediate treatment, while others grow more quickly and need prompt intervention.

Can neuroendocrine tumours be cured?

When caught at an early stage, neuroendocrine tumours can often be cured with surgery. However, even when the tumours have spread and cure isn’t possible, the disease and its symptoms can often be controlled for many years with various treatments.

What causes neuroendocrine tumours?

Researchers don’t know exactly what triggers the abnormal cell growth that causes neuroendocrine tumours. Most cases are sporadic, meaning they occur randomly. However, some rare inherited genetic syndromes like Multiple Endocrine Neoplasia increase the risk of developing these tumours.

How common are neuroendocrine tumours?

Neuroendocrine tumours affect about 6 in 100,000 people worldwide, making them quite rare. However, more people are being diagnosed now than in the past, likely due to improved diagnostic tests that can identify NETs more quickly. They’re rare in children and young adults, with most diagnoses occurring in people aged 50 to 60.

What is the difference between functional and non-functional NETs?

Functional NETs release excess hormones that cause specific symptoms related to those hormones, such as flushing, diarrhoea, or blood sugar problems. Non-functional NETs don’t release enough hormones to cause symptoms, though they can still cause problems if they grow large enough to impact an organ. The distinction affects both symptoms and treatment approaches.

🎯 Key takeaways

  • Neuroendocrine tumours are uncommon cancers that combine characteristics of nerve and hormone-producing cells, developing most often in the digestive system, lungs, or pancreas.
  • Most NETs grow slowly, meaning people can often live for many years with the disease, especially when caught early and treated appropriately.
  • Carcinoid syndrome—a distinctive complication causing flushing, severe diarrhoea, and other symptoms—occurs when tumours produce excessive hormones and can be triggered by certain foods and drinks.
  • The outlook varies greatly depending on the tumour’s location, grade (how quickly cells divide), whether it produces hormones, and whether it has spread to other organs.
  • Living with NETs often means managing an emotional rollercoaster of feeling well for periods while knowing the cancer is still present, creating unique psychological challenges.
  • Treatment options include surgery (potentially curative if caught early), medications that control hormone production, targeted therapies, and innovative approaches like peptide receptor radionuclide therapy.
  • Family and friends play a crucial role in supporting patients through treatment, including helping research and prepare for clinical trials that may offer new treatment options.
  • Even when NETs have spread beyond their original location, the disease and symptoms can often be controlled for many years, allowing patients to maintain good quality of life.